|
Volumn 27, Issue 2, 2014, Pages 175-183
|
Genetic and clinico-pathologic analysis of metastatic uveal melanoma
a b a a a c,d c,d e a a c,d c,d a c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
BAP1 PROTEIN;
GNA11 PROTEIN;
GNAQ PROTEIN;
MUTANT PROTEIN;
SF3B1 PROTEIN;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER PROGNOSIS;
CELL STRUCTURE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
DISEASE SPECIFIC SURVIVAL;
GENETIC ANALYSIS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LOSS OF FUNCTION MUTATION;
METASTATIC UVEA MELANOMA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SPINDLE CELL;
UVEA MELANOMA;
WILD TYPE;
ADULT;
AGED;
COHORT STUDIES;
DNA MUTATIONAL ANALYSIS;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GTP-BINDING PROTEIN ALPHA SUBUNITS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM METASTASIS;
PHOSPHOPROTEINS;
PROGNOSIS;
RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR;
UVEAL NEOPLASMS;
YOUNG ADULT;
|
EID: 84893757118
PISSN: 08933952
EISSN: 15300285
Source Type: Journal
DOI: 10.1038/modpathol.2013.138 Document Type: Article |
Times cited : (69)
|
References (0)
|